ALSO IN THIS MONTH'S ISSUE
Bloated COVID Relief Package Misses Mark
In his final column, John McManus discusses the difficult position pharma companies are in now from a political standpoint and the COVID relief bills.
What I Learned As A Teacher That Made Me A Better Leader
Before I started my career in the pharmaceutical industry, I was a chemistry and biology teacher. While my days in the classroom now feel like a lifetime ago, a day rarely passes that I don't draw upon the range of skills I honed back then.
Turn COVID-19 Supply Chain/Manufacturing Challenges Into Opportunities
While there are no quick and easy fixes to overcoming COVID-related supply chain and manufacturing challenges, they do present opportunities for modernizing supply chains and manufacturing capabilities.
A Q&A With Bernie Zeiher Of Astellas
Bernie Zeiher Of Astellas took on the dual role of CMO & President of Development in April 2018. Here he discusses how he adjusted to that job and some of the best practices he’s learned along the way.
Insights On How Outsourcing Decisions Are Made
How does your company’s approach to making outsourcing decisions compare with others in the industry? Data from ISR’s CDMO outsourcing models report highlights common practices that, when adopted, may improve outsourcing outcomes from drug innovators’ perspectives.
BEYOND THE PRINTED PAGE
BridgeBio’s Neil Kumar Remembers Those Humble Beginnings4/12/2021
Neil Kumar, cofounder and CEO of BridgeBio, a company today valued at more than $10 billion, shares an embarrassing experience of the startup’s humble beginnings.
Why John Fowler Is Not Your Typical Biopharma CEO4/5/2021
John Fowler’s atypical path to becoming a biopharmaceutical company cofounding CEO, began in Congress, along with a decade spent leading companies in completely different industries.
How The CFO Role Has Evolved3/22/2021
Joseph Wolk, J.D., C.P.A, CFO of Johnson & Johnson (J&J), discusses how the CFO role has evolved from the days of monitoring debits and credits.